OBJECTIVE: To report the study of a multigenerational Swiss family with dopa-responsive dystonia (DRD). METHODS: Clinical investigation was made of available family members, including historical and chart reviews. Subject examinations were video recorded. Genetic analysis included a genome-wide linkage study with microsatellite markers (STR), GTP cyclohydrolase I (GCH1) gene sequencing, and dosage analysis. RESULTS: We evaluated 32 individuals, of whom 6 were clinically diagnosed with DRD, with childhood-onset progressive foot dystonia, later generalizing, followed by parkinsonism in the two older patients. The response to levodopa was very good. Two additional patients had late onset dopa-responsive parkinsonism. Three other subjects had DRD symptoms on historical grounds. We found suggestive linkage to the previously reported DYT14 locus, which excluded GCH1. However, further study with more stringent criteria for disease status attribution showed linkage to a larger region, which included GCH1. No mutation was found in GCH1 by gene sequencing but dosage methods identified a novel heterozygous deletion of exons 3 to 6 of GCH1. The mutation was found in seven subjects. One of the patients with dystonia represented a phenocopy. CONCLUSIONS: This study rules out the previously reported DYT14 locus as a cause of disease, as a novel multiexonic deletion was identified in GCH1. This work highlights the necessity of an accurate clinical diagnosis in linkage studies as well as the need for appropriate allele frequencies, penetrance, and phenocopy estimates. Comprehensive sequencing and dosage analysis of known genes is recommended prior to genome-wide linkage analysis.
OBJECTIVE: To report the study of a multigenerational Swiss family with dopa-responsive dystonia (DRD). METHODS: Clinical investigation was made of available family members, including historical and chart reviews. Subject examinations were video recorded. Genetic analysis included a genome-wide linkage study with microsatellite markers (STR), GTP cyclohydrolase I (GCH1) gene sequencing, and dosage analysis. RESULTS: We evaluated 32 individuals, of whom 6 were clinically diagnosed with DRD, with childhood-onset progressive foot dystonia, later generalizing, followed by parkinsonism in the two older patients. The response to levodopa was very good. Two additional patients had late onset dopa-responsive parkinsonism. Three other subjects had DRD symptoms on historical grounds. We found suggestive linkage to the previously reported DYT14 locus, which excluded GCH1. However, further study with more stringent criteria for disease status attribution showed linkage to a larger region, which included GCH1. No mutation was found in GCH1 by gene sequencing but dosage methods identified a novel heterozygous deletion of exons 3 to 6 of GCH1. The mutation was found in seven subjects. One of the patients with dystonia represented a phenocopy. CONCLUSIONS: This study rules out the previously reported DYT14 locus as a cause of disease, as a novel multiexonic deletion was identified in GCH1. This work highlights the necessity of an accurate clinical diagnosis in linkage studies as well as the need for appropriate allele frequencies, penetrance, and phenocopy estimates. Comprehensive sequencing and dosage analysis of known genes is recommended prior to genome-wide linkage analysis.
Authors: C Klein; K Hedrich; K Kabakçi; K Mohrmann; K Wiegers; O Landt; J Hagenah; E Schwinger; P P Pramstaller; L J Ozelius; K Gucuyener; S Aysun; E Demir Journal: Neurology Date: 2002-12-10 Impact factor: 9.910
Authors: Y Furukawa; M Guttman; S P Sparagana; J M Trugman; K Hyland; P Wyatt; A E Lang; G A Rouleau; M Shimadzu; S J Kish Journal: Ann Neurol Date: 2000-04 Impact factor: 10.422
Authors: Erik G Puffenberger; Diane Hu-Lince; Jennifer M Parod; David W Craig; Seth E Dobrin; Andrew R Conway; Elizabeth A Donarum; Kevin A Strauss; Travis Dunckley; Javier F Cardenas; Kara R Melmed; Courtney A Wright; Winnie Liang; Phillip Stafford; C Robert Flynn; D Holmes Morton; Dietrich A Stephan Journal: Proc Natl Acad Sci U S A Date: 2004-07-23 Impact factor: 11.205
Authors: H Grötzsch; G-P Pizzolato; J Ghika; D Schorderet; F J Vingerhoets; T Landis; P R Burkhard Journal: Neurology Date: 2002-06-25 Impact factor: 9.910
Authors: Eduardo López-Laso; Juan José Ochoa-Sepúlveda; Juan José Ochoa-Amor; Enrique Bescansa-Heredero; Rafael Camino-León; Francisco Javier Gascón-Jiménez; Maria Elena Mateos-González; Juan Luis Pérez-Navero; José Ignacio Lao-Villadóniga; Aida Ormazabal; Rafael Artuch; Katrin Beyer Journal: J Neurol Date: 2009-06-16 Impact factor: 4.849
Authors: Ilaria Guella; Holly E Sherman; Silke Appel-Cresswell; Alex Rajput; Ali H Rajput; Matthew J Farrer Journal: Brain Date: 2014-12-13 Impact factor: 13.501
Authors: Jose Felix Marti-Masso; Javier Ruiz-Martínez; Vladimir Makarov; Adolfo López de Munain; Ana Gorostidi; Alberto Bergareche; Seungtai Yoon; Joseph D Buxbaum; Coro Paisán-Ruiz Journal: Hum Genet Date: 2011-09-13 Impact factor: 4.132
Authors: Christian Wider; Sarah Lincoln; Justus C Dachsel; Gregory Kapatos; Michael G Heckman; Nancy N Diehl; Spiridon Papapetropoulos; Deborah Mash; Alex Rajput; Ali H Rajput; Dennis W Dickson; Zbigniew K Wszolek; Matthew J Farrer Journal: Neurosci Lett Date: 2009-06-30 Impact factor: 3.046